The Global Injectable Benzodiazepine Industry is on the verge of unprecedented growth, with projected sales expected to soar to $356 million by the end of 2032, according to a comprehensive study conducted by Future Market Insights (FMI). The analysis reveals a robust 2.7% Compound Annual Growth Rate (CAGR) from 2022 to 2032, signaling a remarkable …